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doi:10.1016/j.pedneo.2011.02.002Background: Hemolytic uremic syndrome (HUS) is an uncommon cause of acute renal failure in
children. In contrast to Western countries, most HUSs in Taiwan are caused by Streptococcus
pneumoniae. In this article, we demonstrate the clinical courses of children with HUS in
Taiwan and try to explain the pathophysiology of complications.
Methods: We retrospectively reviewed the medical records of children with HUS who were
admitted to the Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan,
between January 1997 and February 2008. The clinical courses, laboratory data, complica-
tions, and prognosis were recorded. We divided the patients into dialysis group and
non-dialysis group. The laboratory data for the two groups were expressed as mean, standard
deviation, and range.
Results: Nine patients were enrolled in the study, and all were diagnosed with S pneumoniaee
associated HUS. One patient had meningitis, and the others had pneumonia. The mean
durations of anemia and thrombocytopenia were 19.2 days and 10.2 days, respectively. Five
patients received renal replacement therapy because of oligouria. The average of the peak
total bilirubin levels of patients in the dialysis and non-dialysis groups were 24.6 20.7 mg/dL
and 3.8 1.9 mg/dL, respectively. In addition to one patient who had meningitis, four other
patients experienced central nervous system (CNS) complications. The mean durations of
hypertension in five patients with CNS manifestations and four patients without CNS manifes-
tations were 16.8 7.8 days and 4.8 6.6 days, respectively. Two patients died in acute stage,
and most of the others had regained normal renal function at discharge or during follow-up.
Conclusion: (1) Streptococcus pneumoniae is the most common causative pathogen of HUS in
Taiwan; (2) the mean duration of hypertension in patients with CNS manifestations was mucht of Pediatrics, E-DA Hospital, 1, Yi-Da Rd, Jiau-Shu Tsuen, Yan-Chau Shiang, Kaohsiung County,
.tw (Y.-T. Su).
an Pediatric Association. Published by Elsevier Taiwan LLC. All rights reserved.
74 S.-Y. Chen et allonger than that in patients without CNS manifestations; and (3) the average of the peak total
bilirubin levels of patients in the dialysis group was much higher than that in the patients of the
non-dialysis group.
Copyright ª 2011, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Hemolytic uremic syndrome is characterized by the triad of
microangiopathic hemolytic anemia, thrombocytopenia,
and acute renal failure (ARF). In the literature, Escherichia
coli serotype O157:H7 infection is the most common
etiology of diarrhea-associated hemolytic uremic syndrome
(HUS) (Dþ HUS).1e3 Streptococcus pneumoniae accounts
for nearly 40% of nonenteropathic HUS.2 In Western coun-
tries, S penumoniae was reported to cause 2e5% of all
cases of HUS.1,2,4 Patients with nonenteropathic HUS
require dialysis therapy more often and longer hospitali-
zation compared with Dþ HUS.2 The epidemiology of the
causative pathogen is very different in Taiwan. Huang et
al5 reported seven cases with S pneumoniae HUS in
northern Taiwan from January 2000 to June 2005. During
the same period, only one case of E coli (O157:H7)easso-
ciated HUS was diagnosed in their hospital.5 In this study,
we intended to demonstrate the clinical courses, compli-
cations, and prognosis of children with HUS in Taiwan
and to compare the dialysis group with the non-dialysis
group.
2. Methods
We retrospectively reviewed the medical records of chil-
dren with HUS who were admitted to the Department of
Pediatrics, National Taiwan University Hospital, Taipei,
Taiwan, between January 1997 and February 2008. Clinical
conditions, laboratory data, treatment regimens, comor-
bidities, and prognosis were recorded. The definition of
HUS was (1) microangiopathic anemia (hemoglobin less than
10.5 g/dL) supported by typical blood smear findings, (2)
thrombocytopenia (platelet count less than 150 k/mL), and
(3) ARF manifested with acute elevation of creatinine level
or creatinine level greater than the normal range.6 Some
ARF episodes were accompanied with oligouria (urine
output less than 500 mL/24 hr/1.73 m2).7 We divided the
patients into a dialysis group and a non-dialysis group. The
laboratory data of the two groups were expressed as mean,
standard deviation, and range.
3. Results
Nine patients (4 boys and 5 girls) were enrolled (Table 1).
The age at diagnosis ranged from 9 to 56 months (mean age,
28.2 months). All of them suffered from pneumonia or
empyema caused by S pneumoniae except Patient 2 who
was diagnosed with pneumococcal meningitis. Bacterial
infection was confirmed by cultures from blood, pleural
effusion, or cerebrospinal fluid (CSF) in all of them except
in Patient 7 (Table 2). She had negative culture results fromblood, pleural effusion, and CSF, but positive pneumo-
coccal antigen test result from urine and pleural effusion.
Four of five patients who had empyema received video-
assisted thoracoscopic surgery for decortication. Patient 8
suffered from tension hemothorax in addition to empyema,
and hemostasis was performed through thoracotomy.
ThomseneFriedenreich antigen (T antigen) test was done in
seven patients after anemia, thrombocytopenia, and
elevated creatinine level appeared (Table 2). All the six
patients who were examined in earlier stage had a positive
result, whereas one patient who was examined on the 24th
day of disease onset had a negative result.
The mean duration of anemia was 19.2 days (range, 5e32
days) (Table 2). The mean nadir of anemia was 5.9 g/dL
(range, 4e7.6 g/dL). The mean duration of thrombocyto-
penia was 10.2 days (range, 5e25 days). The mean nadir of
thrombocytopenia was 15 k/mL (range, 1e38 k/mL). In
Patient 9, anemia and thrombocytopenia persisted till the
day she expired.
Oligouria developed in five patients, and the mean onset
was on the seventh day (Table 1). The mean duration of
oligouria in the five patients was 11.4 days (range, 4e30
days). All of these five patients received renal replacement
therapy with continuous veno-venous hemofiltration or
hemodialysis. Two of them also received peritoneal dial-
ysis. The mean duration of dialysis was 10.8 days. A
comparison of the laboratory data between the dialysis and
the non-dialysis groups is shown in Table 3.
Hypertension (blood pressure greater than 95th age-
specific percentile) was found in seven patients, and the
mean duration of hypertension was 14.7 days (Table 1).
Three patients needed antihypertension drugs, including
calcium channel blocker, ß-blocker, or vasodilator. Patient
9 had septic shock and needed inotropic agents. In addition
to Patient 2, who had meningitis, central nervous system
(CNS) manifestations occurred in four other patients. The
manifestations of seizure in Patient 3 were blinking, mouth
twitching, and absent facial expression. Brain computed
tomography showed no hemorrhage, and CSF culture
showed a negative result. Patient 1 had tonic-clonic
seizure. Patient 8 suffered from tension hemothorax
resulting in hypotension and bradycardia; hence, cardio-
pulmonary resuscitation was performed. Three hours later,
there was a seizure attack. The latter two patients did not
have brain image or CSF study. Patient 7 had conscious
disturbance with apathy, and brain magnetic resonance
imaging showed suspected hypertensive encephalopathy.
The mean durations of hypertension in the five patients
with CNS manifestations and in those without CNS mani-
festations were 16.8 days (standard deviation, 7.8 days)
and 4.8 days (standard deviation, 6.6 days), respectively.
Conjugated bilirubin level elevated significantly in
Patients 4, 7, and 9 (total bilirubin more than 30 g/dL)
Table 1 Symptoms, signs, and treatment in hemolytic uremic syndrome patients
Patient
1 2 3 4 5 6 7 8 9
Sex F F M F M M F M F
Age (mo) 9 14 56 23 14 37 48 24 29
Infectious disease E Meningitis E PP E E PP E PP
Days from fever onset to oligouria onset N N 7 10 N N 5 7 7
CNS involvement manifestation S Meningitis S e e e C S e
Days from fever onset to CNS involvement 10 e 18 e e e 19 18 e
Hypertension duration (d) 18 8 21 14 n 5 27 10 Shock
Days from fever onset to discharge 47 22 27 32 48 28 33 39, expired 10, expired
Surgical intervention V e V e V V e T e
Dialysis mode e e CVVH PD, CVVH e e CAVHD CVVH, PD CVVH
Dialysis duration (d) e e 6 9 e e 6 30 3*
* Till the patient expired.
CZ conscious disturbance; CAVHDZ continuous arteriovenous hemodialysis; CNSZ central nervous system; CVVHZ continuous veno-
venous hemofiltration; EZ empyema; FZ female; MZmale; nZ normotension; NZ no oligouria; PDZ peritoneal dialysis;
PPZ pneumonia with pleural effusion; SZ seizure; TZ thoracotomy; VZ video-assisted thoracoscopic surgery with decortication.
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tate aminotransferase and alanine aminotransferase levels.
The total bilirubin levels returned to less than 2 mg/dL in 8
days and 10 days in Patients 4 and 7, respectively. Hyper-
bilirubinemia in Patient 9 persisted till the day she expired.
Patient 7 was also diagnosed as having an acute pancreatitis
with peak amylase and lipase levels up to 590 U/L and
8132 U/L on the 10th day.
Patients who survived had improved renal function
when discharged, though Patients 2 and 7 still had higher
creatinine levels than normal limits. Patient 7 received
follow-up, and the creatinine levels returned to normal 3
months later. Patient 8 had bleeding tendency resulting in
persistent hemothorax and hypovolemic shock. He expired
on the 36th day of hospitalization. Patient 9 suffered from
sudden onset of desaturation and bradycardia that wereTable 2 Laboratory data in hemolytic uremic syndrome patien
Patient
1 2 3
Positive culture result
(Streptococcus penumoniae)
B/C, P/C CSF/C P/C
T antigen N þ þ
Creatinine peak level (mg/dL) 0.5 2.1 2.3
Creatinine level at discharge (mg/dL) 0.3 0.6 0.5
Duration of anemia (d) 19 12 7
Nadir hemoglobin (g/dL) 7.6 6.3 3.8
Duration of thrombocytopenia (d) 11 5 7
Nadir platelet count (k/mL) 38 15 5
Peak total bilirubin (mg/dL) 2x 5.3 1.78
Peak direct bilirubin (mg/dL) 1.1x 3.4 0.8
* Both pneumococcal antigen for urine and pleural effusion were po
y Creatinine level while the patient expired;
z Anemia and thrombocytopenia persisted till the day of expiration
x Bilirubin level was checked only once.
B/CZ bloodculture;CSF/CZ cerebrospinalfluidculture;NZ notdone;
antigen.refractory to cardiopulmonary resuscitation. Extracorpo-
real membrane oxygenation was set; however, it was
discontinued 1 day later because of poor neurologic and
cardiac outcome. Patient 2, who was diagnosed with
meningitis, received ventriculoperitoneal shunt 13 months
after admission because of hydrocephalus, resulting in
acutely increased intracranial pressure.4. Discussion
Escherichia coli serotype O157:H7 is the leading pathogen
resulting in HUS. However, during the study period, there
was no E coli serotype O157:H7eassociated HUS reported in
our hospital; instead, all patients had HUS caused by
S pneumoniae. An earlier report from another tertiaryts
4 5 6 7 8 9
B/C, P/C B/C, P/C B/C All negative* P/C B/C
þ N þ  þ þ
2.3 2.8 1.0 5.9 2.9 3.0
0.5 0.4 0.3 0.9 2.3y 1.7y
25 32 18 28 27 5z
6.8 6.3 5 6.5 4 7
13 11 6 9 25 5z
25 19 1 8 19 5
41 2.4 5.6 31 3.5 45.6
39 e 3.5 23 1.2 44
sitive;
;
P/CZ pleuraleffusion culture;TantigenZ ThomseneFriedenreich
Table 3 A comparison of the laboratory data between the dialysis and the non-dialysis groups
Laboratory data Dialysis group (nZ 5) Non-dialysis group (nZ 4)
Duration of anemia (d) 21.8 9.9; 5e28 20.3 8.4; 12e32
Nadir hemoglobin (g/dL) 5.6 1.6; 3.8e7 6.3 1.1; 5e7.6
Duration of thrombocytopenia (d) 13.5 8.1; 5e25 8.3 3.2; 5e11
Nadir platelet count (k/mL) 12.4 9.1; 5e25 18.3 15.3; 1e38
Peak total bilirubin (mg/dL) 24.6 20.7; 1.78e45.6 3.8 1.9; 2e5.6
Data are mean standard deviation and range.
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contrast to Western countries, E coli serotype O157:H7 is
a rare cause of diarrhea in Taiwan. According to the data
from the Center for Disease Control of Taiwan, only one
case was confirmed of a diagnosis of E coli serotype
O157:H7 infection in March 2010. The infection results for
Dþ HUS are even rarer. All S pneumoniae produce neuro-
minidase, but only a small portion of patients develop HUS.
Patients with S pneumoniaeeassociated HUS having
different anti-T titer compared with normal individuals has
been reported.8 The difference was caused by the presence
or absence of intestinal flora able to express antigen similar
to the T antigen.8 Patients may have more intestinal flora
able to express that kind of antigen, resulting in higher anti-
T titer. Taiwanese may have higher anti-T titer compared
with Caucasians, which result in S pneumoniaeeassociated
HUS being more prevalent. Further investigation is needed to
prove the hypothesis.
Streptococcus pneumoniae produces neuraminidase,
which cleaves N-acetylneuraminic acid from cell membranes
of erythrocytes, platelets, and glomeruli, resulting in the
exposure of the normally hidden T antigen.8,9 Circulating
anti-T IgM reacts with T antigen, which leads to micro-
angiopathic hemolytic anemia. In our series, T antigen test
was done in seven patients, and most of them had positive
results except Patient 7. This may be the result of the
specimen being obtained in the later stage (the 24th day of
disease onset); as Cochran et al8 described, the poly-
agglutination reaction associated with neuraminidase is
usually transient.
CNS complication is the most common of the extrarenal
manifestations in HUS patients.10 Published reports have
discussed CNS complications focusing on Dþ HUS and
seldom mentioned nonenteropathic HUS. CNS complica-
tions occur in 3e20% of patients with enteropathic HUS,
and the incidence may be similar in patients with non-
enteropathic HUS.2,11 The clinical symptoms include irri-
tability, seizure, alternation of consciousness, hemiparesis,
brain stem symptoms, and so on.10e12 The true pathogen-
esis of CNS manifestation is under debate. Fujii et al13 gave
intravenous purified verotoxin 2 to rabbits and found that
the toxin was localized on endothelial cells of capillaries,
ependymal cells, and myelin sheaths. That would lead to
edematous change in the rabbit brain. Cerebral micro-
thrombi or cerebral edema and hypoxic damage were also
described in biopsied patients.14,15 In this series, three
patients encountered seizure attack, and one other patient
had conscious disturbance. It may be possible that anti-T
IgM and T antigen reaction also occurred in the endothelium
of cerebral vessels. T antigen has been found on human
vascular endothelium similar to red cells exposed bybacterial neuraminidase.16 The mean duration of hyper-
tension in patients with CNS manifestations was much
longer than that in patients without CNS manifestations
(16.8 7.8 days vs. 4.8 6.6 days). In addition, magnetic
resonance imaging in Patient 7 showed suspected hyper-
tensive encephalopathy. Hypertension may have a role in
CNS manifestation.10
How hepatocellular injuries occur in S pneumoniaee
associated HUS is unclear till now. The hepatic dysfunctions
did not significantly contribute to morbidity or mortality in
these patients; hence, liver biopsy is seldom performed.17
As shown in Table 3, the average of the peak total bili-
rubin levels of patients in the dialysis group was much
higher than that of the patients in the non-dialysis group
(24.6 20.7 mg/dL vs. 3.8 1.9 mg/dL). Because of the
limitation of small sample size, the statistical tests could
not be performed. Anti-T antibody conjugated with T
antigen of endothelial cells in the liver may lead to
thrombosis and ischemia of hepatocytes. The hepatocytes
with injury may inefficiently excrete the large amount of
bilirubin generated by rapid hemolysis. The more extensive
the anti-T antibody and T antigen reactions were, the more
severe were the ARF and hepatocellular injuries that
developed. The hypothesis may explain the higher peak
total bilirubin level occurring in the dialysis group
compared with that in the non-dialysis group.
The mortality rate of S pneumoniaeeassociated HUS has
been reported, and it ranged from 0% to as high as
36%.2,7,8,18,19 Nathanson and Descheˆnes18 reported 11
patients with S pneumoniaeeinduced HUS whose data were
collected before 1998. In that report, four patients died,
and five patients developed renal insufficiency. More
recently, the mortality rate was much lower and renal
prognosis was much better.5,19 This may be the result of the
improvement in critical care and the understanding of S
pneumoniaeeassociated HUS, allowing earlier diagnosis.
Two of our patients died in spite of undergoing renal
replacement therapy and their biochemical data improving.
A previous report also showed that most patients died
during the early phase of the severe infections, not from
renal failure.18 In the present study, most patients (6 in 7
patients) who survived had normal creatinine level at
discharge or during follow-up. This might mean that if
patients could tide over the acute phase of HUS, they
wound obtain favorable renal outcome.
In conclusion, our results have shown that (1) S pneu-
moniae is the most common causative etiology of HUS in
Taiwan; (2) the mean duration of hypertension in patients
with CNS manifestations was much longer than that in
patients without CNS manifestations; and (3) the average of
the peak total bilirubin levels of patients in the dialysis
Nonenteropathic hemolytic uremic syndrome 77group was much higher than that of the patients in the non-
dialysis group. Points 2 and 3 should be further confirmed in
studies with a larger sample size. Also, the pathophysiology
of hepatocellular injuries and CNS complications need
further investigation.References
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